Casper was previously CEO of ilochip A/S, a venture backed company focused on development of diagnostic biochips. Before this held different positions at H. Lundbeck A/S most recently in corporate business development and strategy where he gained broad international experience. Prior to his work at H. Lundbeck, Casper worked for Novo Nordisk A/S and Niels Clauson-Kaas A/S. While working at H. Lundbeck A/S he was member of the board of directors of the Lundbeck Foundation and Lundbeckfond Invest as an employee representative. Casper has an MSc in organic chemistry and an MBA.